In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Athyrium Opportunities Fund ups investment in BioFire Diagnostics from $25mm to $45mm

Executive Summary

BioFire Diagnostics Inc. (formerly Idaho Technology; DNA analysis and genotyping) has raised a total of $45mm in financing from Athyrium Opportunities Fund. In September 2012, BioFire said it was getting $25mm from Athyrium.

Deal Industry
  • In Vitro Diagnostics
  • Research, Analytical Equipment & Supplies
    • PCR & Amplification Tools
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies

UsernamePublicRestriction

Register